Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

Clinical trial NCT05548283 · RECRUITING

Trial details

NCT number: NCT05548283
Sponsor: Chris Goss
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Cystic Fibrosis Cystic Fibrosis Pulmonary Exacerbation

Start date: 2023-04-23
Primary completion: 2027-05-31
Enrollment: 730

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.